“ ATO and sulforaphane co-treatment augmented apoptotic induction as demonstrated by cleavage of caspase-3, -4 and PARP.”
“Like BTZ, sulforaphane synergistically enhances the cytotoxicity of arsenic trioxide ( ATO), an agent with clinical activity in MM.”
“Our results suggest that sulforaphane deserves further investigation in combination with ATO in the treatment of MM.”
“ Sulforaphane in combination with ATO effectively disrupts protein homeostasis through ROS generation and induction of ER stress to culminate in inhibition of protein secretion and apoptotic induction in MM.”